RACK1 Acts as a Potential Tumor Promoter in Colorectal Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Receptor of activated protein kinase C 1 (RACK1) is implicated in the progression of various cancers.
• The specific role of RACK1 in colorectal cancer (CRC) pathogenesis remains largely undefined.

Purpose of the Study:

• To investigate the biological role and clinical significance of RACK1 in colorectal cancer (CRC).

Main Methods:

• Analysis of RACK1 expression in CRC and normal tissues using TCGA, GEO datasets, and immunohistochemistry.
• Western blotting to assess RACK1 levels in CRC cell lines.
• In vitro functional assays (BrdU, colony formation, wound healing, Transwell invasion) to determine RACK1's impact on cell behavior.

Main Results:

• RACK1 expression was significantly upregulated in CRC tissues compared to adjacent normal tissues across multiple datasets.
• RACK1 was also overexpressed in both CRC and adenoma tissues relative to normal tissues.
• Loss-of-function studies demonstrated that RACK1 promotes CRC cell proliferation, migration, and invasion.

Conclusions:

• RACK1 functions as an oncogene in colorectal cancer, significantly promoting tumor progression.
• RACK1 represents a potential therapeutic target for the management of CRC.